AMLX
Price
$5.64
Change
+$0.24 (+4.44%)
Updated
Nov 1 closing price
3 days until earnings call
VNDA
Price
$4.65
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
2 days until earnings call
Ad is loading...

AMLX vs VNDA

Header iconAMLX vs VNDA Comparison
Open Charts AMLX vs VNDABanner chart's image
Amylyx Pharmaceuticals
Price$5.64
Change+$0.24 (+4.44%)
Volume$1.31M
CapitalizationN/A
Vanda Pharmaceuticals
Price$4.65
Change-$0.00 (-0.00%)
Volume$2.91K
CapitalizationN/A
View a ticker or compare two or three
AMLX vs VNDA Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AMLX vs. VNDA commentary
Nov 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and VNDA is a StrongSell.

COMPARISON
Comparison
Nov 04, 2024
Stock price -- (AMLX: $5.64 vs. VNDA: $4.65)
Brand notoriety: AMLX and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 93% vs. VNDA: 1%
Market capitalization -- AMLX: $383.99M vs. VNDA: $271.63M
AMLX [@Biotechnology] is valued at $383.99M. VNDA’s [@Biotechnology] market capitalization is $271.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $494.31B to $0. The average market capitalization across the [@Biotechnology] industry is $2.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 1 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 1 green, 4 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than VNDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while VNDA’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 3 bearish.
  • VNDA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than VNDA.

Price Growth

AMLX (@Biotechnology) experienced а +6.21% price change this week, while VNDA (@Biotechnology) price change was +2.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

AMLX is expected to report earnings on Mar 26, 2025.

VNDA is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($384M) has a higher market cap than VNDA($272M). VNDA has higher P/E ratio than AMLX: VNDA (126.00) vs AMLX (2.69). VNDA YTD gains are higher at: 10.190 vs. AMLX (-61.685). VNDA has higher annual earnings (EBITDA): -26.54M vs. AMLX (-153.78M). VNDA has more cash in the bank: 388M vs. AMLX (310M). AMLX has less debt than VNDA: AMLX (3.14M) vs VNDA (8.43M). AMLX has higher revenues than VNDA: AMLX (299M) vs VNDA (182M).
AMLXVNDAAMLX / VNDA
Capitalization384M272M141%
EBITDA-153.78M-26.54M579%
Gain YTD-61.68510.190-605%
P/E Ratio2.69126.002%
Revenue299M182M164%
Total Cash310M388M80%
Total Debt3.14M8.43M37%
FUNDAMENTALS RATINGS
VNDA: Fundamental Ratings
VNDA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXVNDA
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PNOCX95.070.48
+0.51%
Putnam Sustainable Leaders C
FCUPX19.290.09
+0.47%
NYLI PineStone U.S. Equity Class P
CLPAX12.720.06
+0.47%
Catalyst Nasdaq-100 Hedged Equity A
JDSCX33.040.10
+0.30%
JPMorgan Small Cap Blend I
CBSYX17.560.01
+0.06%
AB Global Risk Allocation Adv

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with ATRA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+4.44%
ATRA - AMLX
55%
Loosely correlated
N/A
IKNA - AMLX
54%
Loosely correlated
N/A
JAZZ - AMLX
43%
Loosely correlated
N/A
VNDA - AMLX
42%
Loosely correlated
N/A
NTLA - AMLX
41%
Loosely correlated
+4.15%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with AMLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
N/A
AMLX - VNDA
42%
Loosely correlated
+4.44%
IKNA - VNDA
37%
Loosely correlated
N/A
GOSS - VNDA
37%
Loosely correlated
-0.49%
VCYT - VNDA
36%
Loosely correlated
N/A
NTLA - VNDA
36%
Loosely correlated
+4.15%
More